HTGC News: AcelRx Pharmaceuticals Receives $65 Million from the Partial Sale of Zalviso™ European Royalties and Commercial Milestones to PDL BioPharma
Mon, Sep 21, 6:01 AM
This HTGC news release, entitled "AcelRx Pharmaceuticals Receives $65 Million from the Partial Sale of Zalviso™ European Royalties and Commercial Milestones to PDL BioPharma" was released Mon, Sep 21, 6:01 AM through PR Newswire.